The authors found that ‘Mettl3′ is normally expressed in CD34+ hematopoietic stem/progenitor cells (HSPCs) but aberrantly expressed in leukaemia cells as compared to the other tumour-types. This evidence concerns the gene METTL3 and neoplasm.